Stratifying sudden death risk in adults with drug-resistant focal epilepsy: The SUDEP-CARE score.
SUDEP
case-control
epilepsy
risk score
sudden death
Journal
European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311
Informations de publication
Date de publication:
01 2023
01 2023
Historique:
revised:
22
06
2022
received:
15
04
2022
accepted:
24
08
2022
pubmed:
13
9
2022
medline:
17
12
2022
entrez:
12
9
2022
Statut:
ppublish
Résumé
A clinical risk score for sudden unexpected death in epilepsy (SUDEP) in patients with drug-resistant focal epilepsy could help improve prevention. A case-control study was conducted including (i) definite or probable SUDEP cases collected by the French National Sentinel Mortality Epilepsy Network and (ii) control patients from the French national research database of epilepsy monitoring units. Patients with drug-resistant focal epilepsy were eligible. Multiple logistic regressions were performed. After sensitivity analysis and internal validation, a simplified risk score was developed from the selected variables. Sixty-two SUDEP cases and 620 controls were included. Of 21 potential predictors explored, seven were ultimately selected, including generalized seizure frequency (>1/month vs. <1/year: adjusted odds ratio [AOR] 2.6, 95% confidence interval [CI] 1.25-5.41), nocturnal or sleep-related seizures (AOR 4.49, 95% CI 2.68-7.53), current or past depression (AOR 2.0, 95% CI 1.19-3.34) or the ability to alert someone of an oncoming seizure (AOR 0.57, 95% CI 0.33-0.98). After internal validation, a clinically usable score ranging from -1 to 8 was developed, with high discrimination capabilities (area under the receiver operating curve 0.85, 95% CI 0.80-0.90). The threshold of 3 has good sensitivity (82.3%, 95% CI 72.7-91.8), whilst keeping a good specificity (82.7%, 95% CI 79.8-85.7). These results outline the importance of generalized and nocturnal seizures on the occurrence of SUDEP, and show a protective role in the ability to alert someone of an oncoming seizure. The SUDEP-CARE score is promising and will need external validation. Further work, including paraclinical explorations, could improve this risk score.
Sections du résumé
BACKGROUND AND PURPOSE
A clinical risk score for sudden unexpected death in epilepsy (SUDEP) in patients with drug-resistant focal epilepsy could help improve prevention.
METHODS
A case-control study was conducted including (i) definite or probable SUDEP cases collected by the French National Sentinel Mortality Epilepsy Network and (ii) control patients from the French national research database of epilepsy monitoring units. Patients with drug-resistant focal epilepsy were eligible. Multiple logistic regressions were performed. After sensitivity analysis and internal validation, a simplified risk score was developed from the selected variables.
RESULTS
Sixty-two SUDEP cases and 620 controls were included. Of 21 potential predictors explored, seven were ultimately selected, including generalized seizure frequency (>1/month vs. <1/year: adjusted odds ratio [AOR] 2.6, 95% confidence interval [CI] 1.25-5.41), nocturnal or sleep-related seizures (AOR 4.49, 95% CI 2.68-7.53), current or past depression (AOR 2.0, 95% CI 1.19-3.34) or the ability to alert someone of an oncoming seizure (AOR 0.57, 95% CI 0.33-0.98). After internal validation, a clinically usable score ranging from -1 to 8 was developed, with high discrimination capabilities (area under the receiver operating curve 0.85, 95% CI 0.80-0.90). The threshold of 3 has good sensitivity (82.3%, 95% CI 72.7-91.8), whilst keeping a good specificity (82.7%, 95% CI 79.8-85.7).
CONCLUSIONS
These results outline the importance of generalized and nocturnal seizures on the occurrence of SUDEP, and show a protective role in the ability to alert someone of an oncoming seizure. The SUDEP-CARE score is promising and will need external validation. Further work, including paraclinical explorations, could improve this risk score.
Identifiants
pubmed: 36094672
doi: 10.1111/ene.15566
pmc: PMC10087018
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
22-31Informations de copyright
© 2022 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.
Références
Epilepsia. 2010 Jul;51(7):1139-45
pubmed: 20059526
Epilepsy Behav. 2010 Sep;19(1):78-81
pubmed: 20667792
Lancet Neurol. 2013 Oct;12(10):966-77
pubmed: 24012372
Stat Med. 2018 Jun 30;37(14):2252-2266
pubmed: 29682776
J Neurol Neurosurg Psychiatry. 1996 Mar;60(3):297-300
pubmed: 8609507
Epilepsia. 2010 Jun;51(6):1069-77
pubmed: 19889013
Neurology. 2017 Apr 25;88(17):1674-1680
pubmed: 28438841
Epilepsy Res. 2005 Jun;65(1-2):101-15
pubmed: 16005188
Neurology. 2001 Feb 27;56(4):519-25
pubmed: 11222798
Epilepsia. 2016 Jan;57 Suppl 1:46-53
pubmed: 26749016
Neurology. 2020 Jan 28;94(4):e419-e429
pubmed: 31831600
Eur J Neurol. 2023 Jan;30(1):22-31
pubmed: 36094672
Epilepsia. 2021 Jul;62(7):1536-1545
pubmed: 34086290
Curr Opin Neurol. 2019 Apr;32(2):205-212
pubmed: 30694923
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
Seizure. 2015 Feb;25:112-6
pubmed: 25457453
Int J Stat Med Res. 2015;4(3):287-295
pubmed: 27429686
BMC Med Res Methodol. 2009 Jul 28;9:57
pubmed: 19638200
Epilepsia. 2018 Oct;59(10):e157-e160
pubmed: 30159901
Epilepsia. 2016 Jan;57 Suppl 1:4-16
pubmed: 26749012
Epilepsia. 2005;46 Suppl 11:54-61
pubmed: 16393182
Seizure. 2000 Apr;9(3):179-83
pubmed: 10775513
Neurology. 2017 Jul 11;89(2):170-177
pubmed: 28592455
Epilepsia. 2011 Jun;52(6):1150-9
pubmed: 21671925
Lancet. 1999 Mar 13;353(9156):888-93
pubmed: 10093982
Neurology. 2021 May 25;96(21):e2627-e2638
pubmed: 33910939
Front Neurol. 2018 Apr 27;9:281
pubmed: 29755403
Epilepsia. 2012 Feb;53(2):227-33
pubmed: 22191982
J Clin Epidemiol. 2001 Aug;54(8):774-81
pubmed: 11470385
Epilepsy Behav. 2020 Feb;103(Pt B):106419
pubmed: 31648927
Epilepsia. 2012 Feb;53(2):253-7
pubmed: 22192074
Epilepsia. 2012 Feb;53(2):249-52
pubmed: 22191685
Br J Gen Pract. 2011 May;61(586):e271-8
pubmed: 21619751